BACKGROUND: Increased exposure of colonic and rectal epithelial cells to the promitotic and antiapoptotic effects of insulin and insulin-like growth factors (IGF) is hypothesized to increase colorectal cancer risk. METHODS: In a case-control study nested within the Multiethnic Cohort, we attempted to replicate associations for five genetic variants associated with IGF system biomarkers, insulin, or glucose and to examine their association with the risk of colorectal cancer. In a subset of participants, the association between circulating biomarkers and colorectal cancer risk was examined. Unconditional logistic regression was used to calculate ORs and 95% confidence intervals (CI) for genetic variants (1,954 cases/2,587 controls) and serum biomarkers (258 cases/1,701 controls). RESULTS: Associations with circulating biomarkers were replicated in the Multiethnic Cohort for IGF1 rs35767 and for IGFBP3 rs2854744, rs2854746, and rs3110697 (P < 0.05). Homozygous carriers of the glucokinase regulator (GCKR) rs780094 variant T-allele were at a decreased risk of colorectal cancer (OR, 0.77; 95% CI, 0.64-0.92). In risk factor-adjusted models, participants with the highest prediagnostic IGF-II levels were at an increased risk [OR (T1 vs. T3), 1.58; 95% CI, 1.09-2.28; P(trend) = 0.011] and participants with the highest prediagnostic IGF-binding protein (IGFBP)-3 levels were at a decreased risk of colorectal cancer (OR, 0.53; 95% CI, 0.34-0.83; P(trend) = 0.003). CONCLUSION: These data provide further support for a role of prediagnostic IGF and insulin levels in the etiology of colorectal cancer. IMPACT: Future studies attempting to replicate the association between the GCKR rs780094 variant and the risk of colorectal cancer are warranted.
BACKGROUND: Increased exposure of colonic and rectal epithelial cells to the promitotic and antiapoptotic effects of insulin and insulin-like growth factors (IGF) is hypothesized to increase colorectal cancer risk. METHODS: In a case-control study nested within the Multiethnic Cohort, we attempted to replicate associations for five genetic variants associated with IGF system biomarkers, insulin, or glucose and to examine their association with the risk of colorectal cancer. In a subset of participants, the association between circulating biomarkers and colorectal cancer risk was examined. Unconditional logistic regression was used to calculate ORs and 95% confidence intervals (CI) for genetic variants (1,954 cases/2,587 controls) and serum biomarkers (258 cases/1,701 controls). RESULTS: Associations with circulating biomarkers were replicated in the Multiethnic Cohort for IGF1rs35767 and for IGFBP3rs2854744, rs2854746, and rs3110697 (P < 0.05). Homozygous carriers of the glucokinase regulator (GCKR) rs780094 variant T-allele were at a decreased risk of colorectal cancer (OR, 0.77; 95% CI, 0.64-0.92). In risk factor-adjusted models, participants with the highest prediagnostic IGF-II levels were at an increased risk [OR (T1 vs. T3), 1.58; 95% CI, 1.09-2.28; P(trend) = 0.011] and participants with the highest prediagnostic IGF-binding protein (IGFBP)-3 levels were at a decreased risk of colorectal cancer (OR, 0.53; 95% CI, 0.34-0.83; P(trend) = 0.003). CONCLUSION: These data provide further support for a role of prediagnostic IGF and insulin levels in the etiology of colorectal cancer. IMPACT: Future studies attempting to replicate the association between the GCKRrs780094 variant and the risk of colorectal cancer are warranted.
Authors: T Stocks; A Lukanova; M Johansson; S Rinaldi; R Palmqvist; G Hallmans; R Kaaks; P Stattin Journal: Int J Obes (Lond) Date: 2007-09-18 Impact factor: 5.095
Authors: Sharon H Saydah; Elizabeth A Platz; Nader Rifai; Michael N Pollak; Frederick L Brancati; Kathy J Helzlsouer Journal: Cancer Epidemiol Biomarkers Prev Date: 2003-05 Impact factor: 4.254
Authors: Richa Saxena; Benjamin F Voight; Valeriya Lyssenko; Noël P Burtt; Paul I W de Bakker; Hong Chen; Jeffrey J Roix; Sekar Kathiresan; Joel N Hirschhorn; Mark J Daly; Thomas E Hughes; Leif Groop; David Altshuler; Peter Almgren; Jose C Florez; Joanne Meyer; Kristin Ardlie; Kristina Bengtsson Boström; Bo Isomaa; Guillaume Lettre; Ulf Lindblad; Helen N Lyon; Olle Melander; Christopher Newton-Cheh; Peter Nilsson; Marju Orho-Melander; Lennart Råstam; Elizabeth K Speliotes; Marja-Riitta Taskinen; Tiinamaija Tuomi; Candace Guiducci; Anna Berglund; Joyce Carlson; Lauren Gianniny; Rachel Hackett; Liselotte Hall; Johan Holmkvist; Esa Laurila; Marketa Sjögren; Maria Sterner; Aarti Surti; Margareta Svensson; Malin Svensson; Ryan Tewhey; Brendan Blumenstiel; Melissa Parkin; Matthew Defelice; Rachel Barry; Wendy Brodeur; Jody Camarata; Nancy Chia; Mary Fava; John Gibbons; Bob Handsaker; Claire Healy; Kieu Nguyen; Casey Gates; Carrie Sougnez; Diane Gage; Marcia Nizzari; Stacey B Gabriel; Gung-Wei Chirn; Qicheng Ma; Hemang Parikh; Delwood Richardson; Darrell Ricke; Shaun Purcell Journal: Science Date: 2007-04-26 Impact factor: 47.728
Authors: Xuefen Su; Graham A Colditz; Walter C Willett; Laura C Collins; Stuart J Schnitt; James L Connolly; Michael N Pollak; Bernard Rosner; Rulla M Tamimi Journal: Int J Cancer Date: 2010-01-01 Impact factor: 7.396
Authors: Nicola L Beer; Nicholas D Tribble; Laura J McCulloch; Charlotta Roos; Paul R V Johnson; Marju Orho-Melander; Anna L Gloyn Journal: Hum Mol Genet Date: 2009-07-30 Impact factor: 6.150
Authors: Mazda Jenab; Elio Riboli; Rebecca J Cleveland; Teresa Norat; Sabina Rinaldi; Alexandra Nieters; Carine Biessy; Ann Tjønneland; Anja Olsen; Kim Overvad; Henning Grønbaek; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Jakob Linseisen; Heiner Boeing; Tobias Pischon; Dimitrios Trichopoulos; Eleni Oikonomou; Antonia Trichopoulou; Salvatore Panico; Paolo Vineis; Franco Berrino; Rosario Tumino; Giovanna Masala; Petra H Peters; Carla H van Gils; H Bas Bueno-de-Mesquita; Marga C Ocké; Eiliv Lund; Michelle A Mendez; María José Tormo; Aurelio Barricarte; Carmen Martínez-García; Miren Dorronsoro; José Ramón Quirós; Göran Hallmans; Richard Palmqvist; Göran Berglund; Jonas Manjer; Timothy Key; Naomi E Allen; Sheila Bingham; Kay-Tee Khaw; Anne Cust; Rudolf Kaaks Journal: Int J Cancer Date: 2007-07-15 Impact factor: 7.396
Authors: Sripriya Raman; Adda Grimberg; Steven G Waguespack; Bradley S Miller; Charles A Sklar; Lillian R Meacham; Briana C Patterson Journal: J Clin Endocrinol Metab Date: 2015-04-03 Impact factor: 5.958
Authors: Noyko S Stanilov; Iliya A Karakolev; Tashko S Deliysky; Jovcho P Jovchev; Spaska A Stanilova Journal: Mol Biol Rep Date: 2014-09-05 Impact factor: 2.316
Authors: Mai Yamauchi; Paul Lochhead; Yu Imamura; Aya Kuchiba; Xiaoyun Liao; Zhi Rong Qian; Reiko Nishihara; Teppei Morikawa; Kaori Shima; Kana Wu; Edward Giovannucci; Jeffrey A Meyerhardt; Charles S Fuchs; Andrew T Chan; Shuji Ogino Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-04-29 Impact factor: 4.254
Authors: Xiang Shu; Zhishan Chen; Jirong Long; Xingyi Guo; Yaohua Yang; Conghui Qu; Yoon-Ok Ahn; Qiuyin Cai; Graham Casey; Stephen B Gruber; Jeroen R Huyghe; Sun Ha Jee; Mark A Jenkins; Wei-Hua Jia; Keum Ji Jung; Yoichiro Kamatani; Dong-Hyun Kim; Jeongseon Kim; Sun-Seog Kweon; Loic Le Marchand; Koichi Matsuda; Keitaro Matsuo; Polly A Newcomb; Jae Hwan Oh; Jennifer Ose; Isao Oze; Rish K Pai; Zhi-Zhong Pan; Paul D P Pharoah; Mary C Playdon; Ze-Fang Ren; Robert E Schoen; Aesun Shin; Min-Ho Shin; Xiao-Ou Shu; Xiaohui Sun; Catherine M Tangen; Chizu Tanikawa; Cornelia M Ulrich; Franzel J B van Duijnhoven; Bethany Van Guelpen; Alicja Wolk; Michael O Woods; Anna H Wu; Ulrike Peters; Wei Zheng Journal: Cancer Epidemiol Biomarkers Prev Date: 2022-06-01 Impact factor: 4.090